107 related articles for article (PubMed ID: 14613302)
1. Treatment of renal amyloidosis in rheumatoid arthritis requires further investigation: comment on the case report by Elkayam et al.
Ciboddo G; Idone C
Arthritis Rheum; 2003 Nov; 48(11):3299; author reply 3299-300. PubMed ID: 14613302
[No Abstract] [Full Text] [Related]
2. Long-term followup needed to define role of infliximab in treatment of renal amyloidosis: comment on the case report by Elkayam et al.
Tweezer-Zaks N; Langevitz P; Livneh A
Arthritis Rheum; 2003 Nov; 48(11):3298-9; author reply 3299-300. PubMed ID: 14613300
[No Abstract] [Full Text] [Related]
3. Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab.
Elkayam O; Hawkins PN; Lachmann H; Yaron M; Caspi D
Arthritis Rheum; 2002 Oct; 46(10):2571-3. PubMed ID: 12384913
[TBL] [Abstract][Full Text] [Related]
4. Development of fatal tuberculosis in a patient with rheumatoid arthritis after three years of treatment with infliximab: comment on the article by Wolfe et al.
Molenaar ET; Bultink IE; Dijkmans BA; Lems WF
Arthritis Rheum; 2005 Apr; 52(4):1334-6. PubMed ID: 15818690
[No Abstract] [Full Text] [Related]
5. Renal amyloidosis secondary to rheumatoid arthritis: remission of proteinuria and renal function improvement with tocilizumab.
Vinicki JP; De Rosa G; Laborde HA
J Clin Rheumatol; 2013 Jun; 19(4):211-3. PubMed ID: 23669800
[No Abstract] [Full Text] [Related]
6. Is IV infliximab better than IV methylprednisolone for the treatment of patients with RA when methotrexate fails?
Smith MD
Ann Rheum Dis; 2005 Mar; 64(3):512; author reply 512. PubMed ID: 15708914
[No Abstract] [Full Text] [Related]
7. Effect of anti-tumor necrosis factor alpha therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis.
Gonzalez-Juanatey C; Llorca J; Garcia-Porrua C; Martin J; Gonzalez-Gay MA
Arthritis Rheum; 2006 Feb; 55(1):150-3. PubMed ID: 16463428
[No Abstract] [Full Text] [Related]
8. Membranous glomerulopathy associated with rheumatoid arthritis may respond to rituximab.
Pixley J; Wolf B; O'Neill W
Scand J Rheumatol; 2008; 37(4):313-4. PubMed ID: 18612934
[No Abstract] [Full Text] [Related]
9. Improvement with rituximab in a patient with both rheumatoid arthritis and myasthenia gravis.
Kerkeni S; Marotte H; Miossec P
Muscle Nerve; 2008 Oct; 38(4):1343-5. PubMed ID: 18816604
[No Abstract] [Full Text] [Related]
10. [Case report: RAEB in a patient with rheumatoid arthritis treated with methotrexate and infliximab].
D'Alessandro G; Bianco MR; Politis S; Ferrandina C; Rossi G; Altomare E
Reumatismo; 2006; 58(1):59-61. PubMed ID: 16639489
[TBL] [Abstract][Full Text] [Related]
11. Rituximab fixed retreatment versus on-demand retreatment in refractory rheumatoid arthritis: comparison of two B cell depleting treatment strategies.
Teng YK; Tekstra J; Breedveld FC; Lafeber F; Bijlsma JW; van Laar JM
Ann Rheum Dis; 2009 Jun; 68(6):1075-7. PubMed ID: 19435725
[No Abstract] [Full Text] [Related]
12. Increase in methotrexate dose in patients with rheumatoid arthritis who have an inadequate response to infliximab.
Ornetti P; Solau E; Gaudin P; Sibilia J; Berthelot JM; Puechal X; Tavernier C; Maillefert JF;
Ann Rheum Dis; 2005 Sep; 64(9):1379-80. PubMed ID: 16100349
[No Abstract] [Full Text] [Related]
13. Long-term treatment of rheumatoid arthritis with tumour necrosis factor alpha blockade: outcome of ceasing and restarting biologicals.
Buch MH; Marzo-Ortega H; Bingham SJ; Emery P
Rheumatology (Oxford); 2004 Feb; 43(2):243-4. PubMed ID: 14739466
[No Abstract] [Full Text] [Related]
14. [Experiences with infliximab in the treatment of active rheumatoid arthritis and spondyloarthropathy].
Dahlin J; Sørensen SF
Ugeskr Laeger; 2003 Nov; 165(48):4646-9. PubMed ID: 14677464
[No Abstract] [Full Text] [Related]
15. How to dose infliximab in rheumatoid arthritis: new data on a serious issue.
van Vollenhoven RF
Ann Rheum Dis; 2009 Aug; 68(8):1237-9. PubMed ID: 19605741
[No Abstract] [Full Text] [Related]
16. Infusion reaction to infliximab in a patient with rheumatoid arthritis after discontinuation over 1 year and readministration.
Toki H; Momohara S; Tsukahara S; Ikari K
J Rheumatol; 2008 Sep; 35(9):1896-7; author reply 1897. PubMed ID: 18785300
[No Abstract] [Full Text] [Related]
17. Tumor necrosis factor inhibitors for rheumatoid arthritis.
Okamoto H
N Engl J Med; 2006 Nov; 355(19):2047; author reply 2048. PubMed ID: 17099950
[No Abstract] [Full Text] [Related]
18. Timing of DAS28 in infliximab therapy.
Armstrong DJ; Bruce IN
Rheumatology (Oxford); 2005 Sep; 44(9):1203-4; author reply 1204. PubMed ID: 15870143
[No Abstract] [Full Text] [Related]
19. Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis.
Favalli EG; Arreghini M; Arnoldi C; Panni B; Marchesoni A; Tosi S; Pontikaki I
Arthritis Rheum; 2004 Apr; 51(2):301-2. PubMed ID: 15077278
[No Abstract] [Full Text] [Related]
20. Reactions to infliximab in patients with rheumatoid arthritis.
Sakellariou GT; Chatzigiannis I
J Rheumatol; 2005 Jul; 32(7):1411-2. PubMed ID: 15996088
[No Abstract] [Full Text] [Related]
[Next] [New Search]
